Using telepractice for language sampling during COVID-19 pandemic: A scoping review.

Using telepractice for language sampling during COVID-19 pandemic: A scoping review.

Publication date: Oct 01, 2025

IntroductionLanguage sampling is a widely used means of language assessment; it is based on the collection and transcription of a child’s language production in various communicative contexts. The need for social distancing due to the COVID-19 pandemic impacted language sampling and speech and language therapy services in general. The in-person assessment became extremely challenging leading to the immediate increased use of telepractice in speech and language therapy. This scoping review aimed to identify the use of telepractice for language sampling in speech and language therapy during the COVID-19 pandemic. MethodsA scoping review of existing literature was performed to collect evidence on using language sample collection via telepractice. A database search was conducted in PubMed, PsycINFO, Cochrane Library, Mendeley, Electronic, and grey bibliography in 2022. Articles were included if they met the inclusion criteria. The quality of each selected study was assessed using the modified critical appraisal skills program (CASP) checklist. ResultsSystematic searches identified 51 studies with six studies in total meeting the inclusion criteria. The results showed that telepractice was a necessary tool during the pandemic of COVID-19 to conduct language sampling in speech and language assessment. ConclusionSpeech and language therapists (SLTs) effectively collected language samples through telepractice during the COVID-19 pandemic. Although, to date, the literature on language sampling via telepractice is limited. The need for SLTs to rely on telepractice for language sampling warrants further investigation.

Concepts Keywords
Cochrane COVID-19
Library COVID-19 pandemic
Pandemic Humans
Pubmed Language sampling
Therapy Language Therapy
Pandemics
SARS-CoV-2
Speech Therapy
telehealth‌
Telemedicine
telepractice

Semantics

Type Source Name
disease MESH COVID-19 pandemic
disease IDO production
drug DRUGBANK Methionine
disease IDO quality

Original Article

(Visited 2 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *